YM543

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YM543, covering 2008-10-16 to 2008-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects [Phase 2]